RaQualia Pharma Inc
TSE:4579
RaQualia Pharma Inc
TSE:4579
Price:
601 JPY
-1.31%
Market Closed
Updated:
May 8, 2024
RaQualia Pharma Inc
Cash from Operating Activities
|
RaQualia Pharma Inc
Cash from Operating Activities Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
RaQualia Pharma Inc
TSE:4579
|
Cash from Operating Activities
-¥718.6m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
11%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Operating Activities
¥731.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Operating Activities
¥595.3B
|
CAGR 3-Years
47%
|
CAGR 5-Years
47%
|
CAGR 10-Years
25%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Operating Activities
¥283.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
16%
|
CAGR 10-Years
4%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Operating Activities
¥409.9B
|
CAGR 3-Years
26%
|
CAGR 5-Years
28%
|
CAGR 10-Years
23%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Operating Activities
¥216.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
See Also
What is RaQualia Pharma Inc's Cash from Operating Activities?
Cash from Operating Activities
-718.6m
JPY
-718.6m
JPY
Based on the financial report for Dec 31, 2023, RaQualia Pharma Inc's Cash from Operating Activities amounts to -718.6m JPY.
What is RaQualia Pharma Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
11%
11%
The average annual Cash from Operating Activities growth rates for RaQualia Pharma Inc have been -35% over the past three years , -12% over the past five years , and 11% over the past ten years .
You don't have any saved screeners yet
